ClinicalTrials.Veeva

Menu

Molecular Testing to Direct Extent of Initial Thyroid Surgery

University of Pittsburgh logo

University of Pittsburgh

Status and phase

Completed
Phase 2

Conditions

Thyroid Cancer

Treatments

Procedure: Total thyroidectomy with CCND
Procedure: Thyroid lobectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT02947035
STUDY19050280

Details and patient eligibility

About

The research study consists of the participant agreeing to 1) the use of preoperative molecular testing (ThyroSeq) to guide extent of initial surgery and 2) the prospective collection of medical record data related to treatment of thyroid cancer.

Full description

The aim of the proposed pilot study is to use a clinical algorithm that incorporates molecular, clinical and radiographic factors to inform surgical management. This study is the first to propose molecular-directed surgical management for this commonly diagnosed cancer.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Thyroid nodule is >1.5 cm
  • Preoperative FNA biopsy that is positive for papillary thyroid cancer or suspicious for papillary thyroid cancer

Exclusion criteria

  • Prior thyroid/parathyroid surgery
  • Clinical indications for total thyroidectomy including hypothyroidism, history of head or neck radiation when <18 years old
  • Recurrent laryngeal nerve dysfunction
  • Diagnosis of concurrent primary hyperparathyroidism

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Low Risk
Experimental group
Description:
Molecular testing and ultrasound features will be used to predict if thyroid cancer is low risk. Intervention will be to perform thyroid lobectomy.
Treatment:
Procedure: Thyroid lobectomy
High Risk
Experimental group
Description:
Molecular testing and ultrasound features will be used to predict if thyroid cancer is high risk. Intervention will be to perform more aggressive surgery to include total thyroidectomy with CCND.
Treatment:
Procedure: Total thyroidectomy with CCND

Trial contacts and locations

2

Loading...

Central trial contact

Linwah Yip, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems